One-Year Continuous Inhaled Nitric Oxide for Primary Pulmonary Hypertension
- 1 March 2001
- Vol. 119 (3) , 970-973
- https://doi.org/10.1378/chest.119.3.970
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Advances in Pulmonary Laboratory TestingChest, 1999
- A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary HypertensionChest, 1998
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Pulsed Delivery of Inhaled Nitric Oxide to Patients With Primary Pulmonary HypertensionChest, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantationThe Annals of Thoracic Surgery, 1994
- Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndromeIntensive Care Medicine, 1993
- Time‐course and dose‐response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndromeEuropean Journal of Clinical Investigation, 1993
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993
- Inhaled nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992